Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Mayr, Martina (BerichterstatterIn) , Schulte, Nadine (BerichterstatterIn) , Belle, Sebastian (BerichterstatterIn) , Hofheinz, Ralf-Dieter (BerichterstatterIn) , Ebert, Matthias (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: BMC cancer
Year: 2012, Jahrgang: 12
ISSN:1471-2407
Online-Zugang:Verlag, kostenfrei, Volltext: http://www.biomedcentral.com/1471-2407/12/587/abstract
Volltext
Verfasserangaben:Mayr, Martina ... Schulte, Nadine; Belle, Sebastian; Hofheinz, Ralf ... Ebert, Matthias P.

MARC

LEADER 00000caa a2200000 c 4500
001 1447936868
003 DE-627
005 20220810213229.0
007 cr uuu---uuuuu
008 130124s2012 xx |||||o 00| ||eng c
024 7 |a 10.1186/1471-2407-12-587  |2 doi 
035 |a (DE-627)1447936868 
035 |a (DE-576)377936863 
035 |a (DE-599)BSZ377936863 
035 |a (OCoLC)1340457716 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma  |c Mayr, Martina ... Schulte, Nadine; Belle, Sebastian; Hofheinz, Ralf ... Ebert, Matthias P. 
264 1 |c 2012 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 24.01.2013 
700 1 |a Mayr, Martina  |d 1974-  |0 (DE-588)132078546  |0 (DE-627)517881500  |0 (DE-576)298931893  |4 oth 
700 1 |a Schulte, Nadine  |d 1981-  |0 (DE-588)138942404  |0 (DE-627)703158511  |0 (DE-576)308939069  |4 oth 
700 1 |a Belle, Sebastian  |d 1976-  |0 (DE-588)134303415  |0 (DE-627)69224140X  |0 (DE-576)278646646  |4 oth 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 oth 
700 1 |a Ebert, Matthias  |d 1968-  |0 (DE-588)1030133522  |0 (DE-627)734827083  |0 (DE-576)377938432  |4 oth 
773 0 8 |i In  |t BMC cancer  |d London : BioMed Central, 2001  |g 12(2012) Artikel-Nr. 587, 7 S.  |h Online-Ressource  |w (DE-627)326643710  |w (DE-600)2041352-X  |w (DE-576)107014645  |x 1471-2407  |7 nnas  |a Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma 
773 1 8 |g volume:12  |g year:2012  |g extent:7  |a Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma 
856 4 0 |u http://www.biomedcentral.com/1471-2407/12/587/abstract  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20130124 
993 |a Article 
994 |a 2012 
998 |g 1030133522  |a Ebert, Matthias  |m 1030133522:Ebert, Matthias  |d 60000  |d 61100  |e 60000PE1030133522  |e 61100PE1030133522  |k 0/60000/  |k 1/60000/61100/  |p 9  |y j 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 5 
998 |g 134303415  |a Belle, Sebastian  |m 134303415:Belle, Sebastian  |d 60000  |d 61100  |e 60000PB134303415  |e 61100PB134303415  |k 0/60000/  |k 1/60000/61100/  |p 4 
998 |g 138942404  |a Schulte, Nadine  |m 138942404:Schulte, Nadine  |d 60000  |d 61100  |e 60000PS138942404  |e 61100PS138942404  |k 0/60000/  |k 1/60000/61100/  |p 3 
999 |a KXP-PPN1447936868  |e 2736184416 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"recId":"1447936868","id":{"eki":["1447936868"],"doi":["10.1186/1471-2407-12-587"]},"physDesc":[{"extent":"7 S."}],"note":["Gesehen am: 24.01.2013"],"relHost":[{"note":["Gesehen am 22.05.20"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinomaBMC cancer","id":{"zdb":["2041352-X"],"issn":["1471-2407"],"eki":["326643710"]},"origin":[{"dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-","publisherPlace":"London ; Berlin ; Heidelberg"}],"recId":"326643710","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2001 -"],"part":{"year":"2012","text":"12(2012) Artikel-Nr. 587, 7 S.","volume":"12","extent":"7"},"language":["eng"],"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}]}],"name":{"displayForm":["Mayr, Martina ... Schulte, Nadine; Belle, Sebastian; Hofheinz, Ralf ... Ebert, Matthias P."]},"person":[{"family":"Mayr","display":"Mayr, Martina","given":"Martina","role":"oth"},{"family":"Schulte","display":"Schulte, Nadine","role":"oth","given":"Nadine"},{"family":"Belle","display":"Belle, Sebastian","role":"oth","given":"Sebastian"},{"role":"oth","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter","family":"Hofheinz"},{"family":"Ebert","role":"oth","given":"Matthias","display":"Ebert, Matthias"}],"title":[{"title":"Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma","title_sort":"Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma"}],"language":["eng"]} 
SRT |a PHASEISTUD2012